Logo image of USAS

AMERICAS GOLD AND SILVER COR (USAS) Stock Fundamental Analysis

USA - NYSEARCA:USAS - CA03062D8035 - Common Stock

4.83 USD
+0.37 (+8.3%)
Last: 10/15/2025, 8:05:03 PM
4.8694 USD
+0.04 (+0.82%)
After Hours: 10/15/2025, 8:05:03 PM
Fundamental Rating

2

USAS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. USAS has a bad profitability rating. Also its financial health evaluation is rather negative. USAS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year USAS has reported negative net income.
In the past year USAS has reported a negative cash flow from operations.
In the past 5 years USAS always reported negative net income.
USAS had a negative operating cash flow in each of the past 5 years.
USAS Yearly Net Income VS EBIT VS OCF VS FCFUSAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -24.42%, USAS is doing worse than 82.69% of the companies in the same industry.
With a Return On Equity value of -106.01%, USAS is not doing good in the industry: 89.10% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -24.42%
ROE -106.01%
ROIC N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
USAS Yearly ROA, ROE, ROICUSAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

USAS has a Gross Margin (11.89%) which is in line with its industry peers.
In the last couple of years the Gross Margin of USAS has grown nicely.
The Profit Margin and Operating Margin are not available for USAS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
USAS Yearly Profit, Operating, Gross MarginsUSAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

USAS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, USAS has more shares outstanding
Compared to 5 years ago, USAS has more shares outstanding
Compared to 1 year ago, USAS has an improved debt to assets ratio.
USAS Yearly Shares OutstandingUSAS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
USAS Yearly Total Debt VS Total AssetsUSAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.56, we must say that USAS is in the distress zone and has some risk of bankruptcy.
USAS's Altman-Z score of 0.56 is on the low side compared to the rest of the industry. USAS is outperformed by 87.82% of its industry peers.
USAS has a Debt/Equity ratio of 1.09. This is a high value indicating a heavy dependency on external financing.
USAS has a Debt to Equity ratio of 1.09. This is amonst the worse of the industry: USAS underperforms 87.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACCN/A
WACC8.98%
USAS Yearly LT Debt VS Equity VS FCFUSAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.14 indicates that USAS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.14, USAS is not doing good in the industry: 81.41% of the companies in the same industry are doing better.
A Quick Ratio of 1.03 indicates that USAS should not have too much problems paying its short term obligations.
The Quick ratio of USAS (1.03) is worse than 67.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.03
USAS Yearly Current Assets VS Current LiabilitesUSAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for USAS have decreased strongly by -75.00% in the last year.
Looking at the last year, USAS shows a small growth in Revenue. The Revenue has grown by 5.49% in the last year.
Measured over the past years, USAS shows a quite strong growth in Revenue. The Revenue has been growing by 11.40% on average per year.
EPS 1Y (TTM)-75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%-14.86%

3.2 Future

The Earnings Per Share is expected to grow by 30.30% on average over the next years. This is a very strong growth
USAS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.17% yearly.
EPS Next Y64.87%
EPS Next 2Y43.99%
EPS Next 3Y32.97%
EPS Next 5Y30.3%
Revenue Next Year15.08%
Revenue Next 2Y45.8%
Revenue Next 3Y42.61%
Revenue Next 5Y31.17%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USAS Yearly Revenue VS EstimatesUSAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
USAS Yearly EPS VS EstimatesUSAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.5 -0.5 -1 -1.5 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

USAS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 191.29, the valuation of USAS can be described as expensive.
USAS's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of USAS to the average of the S&P500 Index (23.04), we can say USAS is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 191.29
USAS Price Earnings VS Forward Price EarningsUSAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USAS Per share dataUSAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as USAS's earnings are expected to grow with 32.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.99%
EPS Next 3Y32.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for USAS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAS GOLD AND SILVER COR

NYSEARCA:USAS (10/15/2025, 8:05:03 PM)

After market: 4.8694 +0.04 (+0.82%)

4.83

+0.37 (+8.3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-11 2025-08-11/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners36.7%
Inst Owner Change0%
Ins Owners23.07%
Ins Owner Change0%
Market Cap1.31B
Analysts80
Price Target3.39 (-29.81%)
Short Float %N/A
Short Ratio1.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)163.1%
PT rev (3m)196.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-157.12%
EPS NY rev (3m)-242.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-14.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 191.29
P/S 13.18
P/FCF N/A
P/OCF N/A
P/B 23.33
P/tB 23.33
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)0.03
Fwd EY0.52%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.37
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.42%
ROE -106.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.89%
FCFM N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
F-Score2
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 115.82%
Cap/Sales 27.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.03
Altman-Z 0.56
F-Score2
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)88.58%
Cap/Depr(5y)98.19%
Cap/Sales(3y)20.94%
Cap/Sales(5y)26.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y64.87%
EPS Next 2Y43.99%
EPS Next 3Y32.97%
EPS Next 5Y30.3%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%-14.86%
Revenue Next Year15.08%
Revenue Next 2Y45.8%
Revenue Next 3Y42.61%
Revenue Next 5Y31.17%
EBIT growth 1Y-78.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-708.39%
EBIT Next 3Y258.39%
EBIT Next 5Y146.33%
FCF growth 1Y-2.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.55%
OCF growth 3YN/A
OCF growth 5YN/A